April 2016

The EUnetHTA JA 2 activities addressed all relevant phases of the Life Cycle of health technology development including the pre-licensing phase (in early scientific advice (Early Dialogues) and market entry through the early assessments of the evidence in rapid REAs

The European Medicines Agency (EMA) and the European network for Health Technology Assessment (EUnetHTA) published today a report on their implementation of the joint work plan covering the period between November 2012 and December 2015.
The EMA-EUnetHTA collaboration aims to create